This week we have another article about the value of diabetes education and self management training (See this week’s Item #2, Behavioral and Educational Interventions Effective for Patients with Poorly Controlled Diabetes). This makes over 30 in the past year and apparently our elected officials are taking notice. There is …

Introducing … the dLife Healthy, Low Carb Snack List! Snacks can be a double-edged sword for people with diabetes. They may help stave off hunger and overeating, while keeping blood sugar levels from dropping too low. But serious snack attacks can also derail your best efforts to eat healthy and manage …

Bydureon Kit (Not Yet Approved in the US) The new Bydureon once a week GLP-1 may be available in January 2012. Unlike the other currently available GLP-1’s, Bydureon requires reconstitution before its use in a “Connect, Shake, Inject” system. A pen for Bydureon is currently under development. Bydureon is not …

This will come as little surprise to those with kids but being a parent speeds up weight gain over a lifetime, according to a new study from researchers at the University of Texas at Austin and other universities. They analyzed data from a national longitudinal survey that tracked changes in …

“There are some major errors in their estimations,” says Jason Block, the study’s lead researcher and an instructor at Harvard Medical School. Block and colleagues surveyed 547 people, ages 11 to 20, as they left five restaurant chains, including McDonald’s, Burger King, Subway, Dunkin’ Donuts and Wendy’s. Adolescents were asked …

Race and ethnicity may influence A1c results and, therefore, the diagnostic accuracy of the test. Researchers examined the sensitivity and specificity of A1c as a diagnostic test for diabetes and prediabetes in 482 non-pregnant Arab adults. A1c levels were 5.9% in 52 individuals with undiagnosed diabetes, 5.2% in 223 individuals …

  Men apparently develop type 2 diabetes with less weight gain than women a finding that may help explain why men have higher rates of diabetes in many parts of the world….

All participants showed glycemic improvement but the structured behavioral group showed greater improvements compared to the other two treatment groups.…

Known as Juvisync (Merck), the new medication combines sitagliptin (Januvia, Merck), a dipeptidyl peptidase-4 (DPP-4) inhibitor used for glycemia control, with the cholesterol-lowering simvastatin.…

The investigational weight-loss combination of naltrexone standard release and bupropion standard release (Contrave) reduces the predicted 10-year risk of cardiovascular events, an analysis of four phase III trials showed.…